UniProt ID | KANK2_HUMAN | |
---|---|---|
UniProt AC | Q63ZY3 | |
Protein Name | KN motif and ankyrin repeat domain-containing protein 2 | |
Gene Name | KANK2 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 851 | |
Subcellular Localization | Cytoplasm. Mitochondrion. | |
Protein Description | Involved in transcription regulation by sequestering nuclear receptor coactivators, such as NCOA1, NCOA2 and NCOA3, in the cytoplasm; the function is deregulated by phosphorylation. Involved in the negative control of vitamin D receptor signaling pathway. [PubMed: 24671081 May be involved in the control of cytoskeleton formation by regulating actin polymerization. Involved in regulation of caspase-independent apoptosis; proposed to sequester AIFM1 in mitochondria and apoptotic stimuli lead to its proteasomal degradation allowing the release of AIFM1 to the nucleus] | |
Protein Sequence | MAQVLHVPAPFPGTPGPASPPAFPAKDPDPPYSVETPYGYRLDLDFLKYVDDIEKGHTLRRVAVQRRPRLSSLPRGPGSWWTSTESLCSNASGDSRHSAYSYCGRGFYPQYGALETRGGFNPRVERTLLDARRRLEDQAATPTGLGSLTPSAAGSTASLVGVGLPPPTPRSSGLSTPVPPSAGHLAHVREQMAGALRKLRQLEEQVKLIPVLQVKLSVLQEEKRQLTVQLKSQKFLGHPTAGRGRSELCLDLPDPPEDPVALETRSVGTWVRERDLGMPDGEAALAAKVAVLETQLKKALQELQAAQARQADPQPQAWPPPDSPVRVDTVRVVEGPREVEVVASTAAGAPAQRAQSLEPYGTGLRALAMPGRPESPPVFRSQEVVETMCPVPAAATSNVHMVKKISITERSCDGAAGLPEVPAESSSSPPGSEVASLTQPEKSTGRVPTQEPTHREPTRQAASQESEEAGGTGGPPAGVRSIMKRKEEVADPTAHRRSLQFVGVNGGYESSSEDSSTAENISDNDSTENEAPEPRERVPSVAEAPQLRPAGTAAAKTSRQECQLSRESQHIPTAEGASGSNTEEEIRMELSPDLISACLALEKYLDNPNALTERELKVAYTTVLQEWLRLACRSDAHPELVRRHLVTFRAMSARLLDYVVNIADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGSTALMVALDAGQSEIASMLYSRMNIKCSFAPMSDDESPTSSSAEE | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
14 | Phosphorylation | VPAPFPGTPGPASPP CCCCCCCCCCCCCCC | 25.88 | 29255136 | |
14 (in isoform 2) | Phosphorylation | - | 25.88 | 27251275 | |
19 | Phosphorylation | PGTPGPASPPAFPAK CCCCCCCCCCCCCCC | 34.25 | 29255136 | |
19 (in isoform 2) | Phosphorylation | - | 34.25 | 24719451 | |
32 | Phosphorylation | AKDPDPPYSVETPYG CCCCCCCCCCCCCCC | 30.64 | 28857561 | |
33 | Phosphorylation | KDPDPPYSVETPYGY CCCCCCCCCCCCCCE | 21.17 | 26074081 | |
36 | Phosphorylation | DPPYSVETPYGYRLD CCCCCCCCCCCEEEE | 21.47 | 23607784 | |
38 | Phosphorylation | PYSVETPYGYRLDLD CCCCCCCCCEEEECH | 33.92 | 23607784 | |
40 | Phosphorylation | SVETPYGYRLDLDFL CCCCCCCEEEECHHH | 11.36 | 23607784 | |
48 | Ubiquitination | RLDLDFLKYVDDIEK EEECHHHHHHHHHHH | 43.13 | 21906983 | |
48 (in isoform 1) | Ubiquitination | - | 43.13 | 21906983 | |
48 (in isoform 2) | Ubiquitination | - | 43.13 | 21906983 | |
48 (in isoform 3) | Ubiquitination | - | 43.13 | 21906983 | |
58 | Phosphorylation | DDIEKGHTLRRVAVQ HHHHHCCCCHHHHHH | 30.54 | 18212344 | |
71 | Phosphorylation | VQRRPRLSSLPRGPG HHCCCCHHHCCCCCC | 30.98 | 23927012 | |
72 | Phosphorylation | QRRPRLSSLPRGPGS HCCCCHHHCCCCCCC | 47.16 | 28355574 | |
72 (in isoform 2) | Phosphorylation | - | 47.16 | 24719451 | |
79 | Phosphorylation | SLPRGPGSWWTSTES HCCCCCCCCCCCHHH | 23.67 | 28857561 | |
82 | Phosphorylation | RGPGSWWTSTESLCS CCCCCCCCCHHHHHC | 21.36 | 30576142 | |
83 | Phosphorylation | GPGSWWTSTESLCSN CCCCCCCCHHHHHCC | 19.22 | 22617229 | |
83 (in isoform 2) | Phosphorylation | - | 19.22 | 24719451 | |
84 | Phosphorylation | PGSWWTSTESLCSNA CCCCCCCHHHHHCCC | 23.40 | 26657352 | |
84 (in isoform 2) | Phosphorylation | - | 23.40 | 27251275 | |
86 | Phosphorylation | SWWTSTESLCSNASG CCCCCHHHHHCCCCC | 34.46 | 26657352 | |
86 (in isoform 2) | Phosphorylation | - | 34.46 | 27251275 | |
89 | Phosphorylation | TSTESLCSNASGDSR CCHHHHHCCCCCCCC | 40.50 | 27251275 | |
92 | Phosphorylation | ESLCSNASGDSRHSA HHHHCCCCCCCCCCC | 47.59 | 22777824 | |
92 (in isoform 2) | Phosphorylation | - | 47.59 | 24719451 | |
95 | Phosphorylation | CSNASGDSRHSAYSY HCCCCCCCCCCCHHH | 35.10 | 22617229 | |
98 | Phosphorylation | ASGDSRHSAYSYCGR CCCCCCCCCHHHCCC | 28.00 | 26356563 | |
100 | Phosphorylation | GDSRHSAYSYCGRGF CCCCCCCHHHCCCCC | 11.82 | 26356563 | |
101 | Phosphorylation | DSRHSAYSYCGRGFY CCCCCCHHHCCCCCC | 17.42 | 26356563 | |
101 (in isoform 2) | Phosphorylation | - | 17.42 | 27251275 | |
102 | Phosphorylation | SRHSAYSYCGRGFYP CCCCCHHHCCCCCCC | 6.05 | 26356563 | |
105 | Dimethylation | SAYSYCGRGFYPQYG CCHHHCCCCCCCCCC | 28.61 | - | |
105 | Methylation | SAYSYCGRGFYPQYG CCHHHCCCCCCCCCC | 28.61 | 24129315 | |
111 | Phosphorylation | GRGFYPQYGALETRG CCCCCCCCCCHHCCC | 10.40 | 7474189 | |
111 (in isoform 2) | Phosphorylation | - | 10.40 | 27642862 | |
117 | Dimethylation | QYGALETRGGFNPRV CCCCHHCCCCCCHHH | 33.58 | - | |
117 | Methylation | QYGALETRGGFNPRV CCCCHHCCCCCCHHH | 33.58 | - | |
123 | Methylation | TRGGFNPRVERTLLD CCCCCCHHHHHHHHH | 43.99 | - | |
127 | Phosphorylation | FNPRVERTLLDARRR CCHHHHHHHHHHHHH | 20.40 | 28555341 | |
141 | Phosphorylation | RLEDQAATPTGLGSL HHHHCCCCCCCCCCC | 25.13 | 30815301 | |
143 | Phosphorylation | EDQAATPTGLGSLTP HHCCCCCCCCCCCCC | 40.46 | 22210691 | |
147 | Phosphorylation | ATPTGLGSLTPSAAG CCCCCCCCCCCCCCC | 33.83 | 26657352 | |
149 | Phosphorylation | PTGLGSLTPSAAGST CCCCCCCCCCCCCCC | 19.52 | 27251275 | |
151 | Phosphorylation | GLGSLTPSAAGSTAS CCCCCCCCCCCCCCE | 26.05 | 26657352 | |
155 | Phosphorylation | LTPSAAGSTASLVGV CCCCCCCCCCEEEEC | 18.97 | 26657352 | |
155 (in isoform 2) | Phosphorylation | - | 18.97 | 27251275 | |
156 | Phosphorylation | TPSAAGSTASLVGVG CCCCCCCCCEEEECC | 21.24 | 26657352 | |
158 | Phosphorylation | SAAGSTASLVGVGLP CCCCCCCEEEECCCC | 24.55 | 26657352 | |
158 (in isoform 2) | Phosphorylation | - | 24.55 | 24719451 | |
168 | Phosphorylation | GVGLPPPTPRSSGLS ECCCCCCCCCCCCCC | 36.79 | 26657352 | |
168 (in isoform 2) | Phosphorylation | - | 36.79 | 27251275 | |
171 | Phosphorylation | LPPPTPRSSGLSTPV CCCCCCCCCCCCCCC | 29.93 | 23927012 | |
171 (in isoform 2) | Phosphorylation | - | 29.93 | 24719451 | |
172 | Phosphorylation | PPPTPRSSGLSTPVP CCCCCCCCCCCCCCC | 45.06 | 28355574 | |
172 (in isoform 2) | Phosphorylation | - | 45.06 | 24719451 | |
175 | Phosphorylation | TPRSSGLSTPVPPSA CCCCCCCCCCCCCCC | 33.90 | 23927012 | |
175 (in isoform 2) | Phosphorylation | - | 33.90 | 24719451 | |
176 | Phosphorylation | PRSSGLSTPVPPSAG CCCCCCCCCCCCCCC | 33.09 | 28355574 | |
176 (in isoform 2) | Phosphorylation | - | 33.09 | 24719451 | |
181 | Phosphorylation | LSTPVPPSAGHLAHV CCCCCCCCCCHHHHH | 40.59 | 23927012 | |
223 | Malonylation | LSVLQEEKRQLTVQL HHHHHHHHHHHEEEE | 44.70 | 26320211 | |
223 | Ubiquitination | LSVLQEEKRQLTVQL HHHHHHHHHHHEEEE | 44.70 | - | |
223 (in isoform 2) | Ubiquitination | - | 44.70 | - | |
231 | Methylation | RQLTVQLKSQKFLGH HHHEEEECCHHHCCC | 33.48 | - | |
231 | Ubiquitination | RQLTVQLKSQKFLGH HHHEEEECCHHHCCC | 33.48 | 29967540 | |
232 | Phosphorylation | QLTVQLKSQKFLGHP HHEEEECCHHHCCCC | 47.39 | 27251275 | |
232 (in isoform 2) | Phosphorylation | - | 47.39 | 27251275 | |
234 | Acetylation | TVQLKSQKFLGHPTA EEEECCHHHCCCCCC | 50.04 | 26051181 | |
234 | Ubiquitination | TVQLKSQKFLGHPTA EEEECCHHHCCCCCC | 50.04 | 29967540 | |
240 | Phosphorylation | QKFLGHPTAGRGRSE HHHCCCCCCCCCCCC | 35.75 | 27251275 | |
240 (in isoform 2) | Phosphorylation | - | 35.75 | 27251275 | |
243 | Methylation | LGHPTAGRGRSELCL CCCCCCCCCCCCEEC | 34.58 | - | |
246 | Phosphorylation | PTAGRGRSELCLDLP CCCCCCCCCEECCCC | 37.43 | 26657352 | |
246 (in isoform 2) | Phosphorylation | - | 37.43 | 27251275 | |
278 | Sulfoxidation | VRERDLGMPDGEAAL EHHHHCCCCCHHHHH | 3.39 | 30846556 | |
288 | Ubiquitination | GEAALAAKVAVLETQ HHHHHHHHHHHHHHH | 25.72 | 29967540 | |
297 | Malonylation | AVLETQLKKALQELQ HHHHHHHHHHHHHHH | 26.61 | 26320211 | |
297 | Ubiquitination | AVLETQLKKALQELQ HHHHHHHHHHHHHHH | 26.61 | 29967540 | |
298 | Malonylation | VLETQLKKALQELQA HHHHHHHHHHHHHHH | 64.02 | 26320211 | |
323 | Phosphorylation | QAWPPPDSPVRVDTV CCCCCCCCCCEEEEE | 30.94 | 22167270 | |
323 (in isoform 2) | Phosphorylation | - | 30.94 | 24719451 | |
329 | Phosphorylation | DSPVRVDTVRVVEGP CCCCEEEEEEEEECC | 13.83 | 22167270 | |
344 | O-linked_Glycosylation | REVEVVASTAAGAPA CEEEEEEECCCCCCH | 13.63 | 28657654 | |
344 | Phosphorylation | REVEVVASTAAGAPA CEEEEEEECCCCCCH | 13.63 | 26074081 | |
345 | Phosphorylation | EVEVVASTAAGAPAQ EEEEEEECCCCCCHH | 15.70 | 26074081 | |
356 | Phosphorylation | APAQRAQSLEPYGTG CCHHHHHCCCCCCCC | 33.44 | 21082442 | |
356 (in isoform 2) | Phosphorylation | - | 33.44 | 24719451 | |
360 | Phosphorylation | RAQSLEPYGTGLRAL HHHCCCCCCCCCHHH | 20.25 | 7594775 | |
360 (in isoform 2) | Phosphorylation | - | 20.25 | 27642862 | |
362 | Phosphorylation | QSLEPYGTGLRALAM HCCCCCCCCCHHHCC | 27.48 | 26074081 | |
375 | Phosphorylation | AMPGRPESPPVFRSQ CCCCCCCCCCCCCCH | 36.87 | 29255136 | |
375 (in isoform 2) | Phosphorylation | - | 36.87 | 24719451 | |
381 | Phosphorylation | ESPPVFRSQEVVETM CCCCCCCCHHHHHHH | 21.16 | 29514088 | |
387 | Phosphorylation | RSQEVVETMCPVPAA CCHHHHHHHCCCCCH | 16.68 | 29514088 | |
406 | Phosphorylation | VHMVKKISITERSCD EEEEEEEEECCCCCC | 32.13 | 23911959 | |
406 (in isoform 2) | Phosphorylation | - | 32.13 | 24719451 | |
408 | Phosphorylation | MVKKISITERSCDGA EEEEEEECCCCCCCC | 20.68 | 24972180 | |
411 | Phosphorylation | KISITERSCDGAAGL EEEECCCCCCCCCCC | 15.44 | 27251275 | |
425 | Phosphorylation | LPEVPAESSSSPPGS CCCCCCCCCCCCCCC | 37.31 | 27251789 | |
425 (in isoform 2) | Phosphorylation | - | 37.31 | 24719451 | |
426 | Phosphorylation | PEVPAESSSSPPGSE CCCCCCCCCCCCCCH | 26.75 | 26657352 | |
427 | Phosphorylation | EVPAESSSSPPGSEV CCCCCCCCCCCCCHH | 57.02 | 26657352 | |
428 | Phosphorylation | VPAESSSSPPGSEVA CCCCCCCCCCCCHHH | 36.74 | 25159151 | |
428 (in isoform 2) | Phosphorylation | - | 36.74 | 27251275 | |
432 | Phosphorylation | SSSSPPGSEVASLTQ CCCCCCCCHHHCCCC | 34.37 | 27251275 | |
438 | Phosphorylation | GSEVASLTQPEKSTG CCHHHCCCCCCCCCC | 39.31 | 30576142 | |
443 | Phosphorylation | SLTQPEKSTGRVPTQ CCCCCCCCCCCCCCC | 34.14 | 24275569 | |
444 | Phosphorylation | LTQPEKSTGRVPTQE CCCCCCCCCCCCCCC | 39.82 | 28555341 | |
463 | Phosphorylation | EPTRQAASQESEEAG CCCHHHHHHHHHHHC | 37.18 | 26657352 | |
472 | Phosphorylation | ESEEAGGTGGPPAGV HHHHHCCCCCCCHHH | 37.74 | 18669648 | |
472 (in isoform 2) | Phosphorylation | - | 37.74 | 28985074 | |
477 (in isoform 2) | Phosphorylation | - | 32.04 | 25850435 | |
478 (in isoform 2) | Phosphorylation | - | 22.57 | 26657352 | |
493 | Phosphorylation | KEEVADPTAHRRSLQ HHHHCCCCCCCCCEE | 35.33 | 20393185 | |
540 | Phosphorylation | EPRERVPSVAEAPQL CCHHHCCCHHHCCCC | 30.97 | 29255136 | |
548 | Phosphorylation | VAEAPQLRPAGTAAA HHHCCCCCCCCCHHH | 17.49 | 32645325 | |
548 (in isoform 2) | Phosphorylation | - | 17.49 | 24719451 | |
552 | Phosphorylation | PQLRPAGTAAAKTSR CCCCCCCCHHHHHHH | 18.41 | 23927012 | |
565 | Phosphorylation | SRQECQLSRESQHIP HHHHHHHCHHHCCCC | 14.23 | 27251275 | |
568 | Phosphorylation | ECQLSRESQHIPTAE HHHHCHHHCCCCCCC | 26.42 | 26657352 | |
573 | Phosphorylation | RESQHIPTAEGASGS HHHCCCCCCCCCCCC | 36.42 | 29255136 | |
576 (in isoform 2) | Phosphorylation | - | 23.68 | 27251275 | |
578 | Phosphorylation | IPTAEGASGSNTEEE CCCCCCCCCCCCHHH | 54.32 | 26657352 | |
580 | Phosphorylation | TAEGASGSNTEEEIR CCCCCCCCCCHHHHH | 37.78 | 26657352 | |
582 | Phosphorylation | EGASGSNTEEEIRME CCCCCCCCHHHHHHH | 46.61 | 29255136 | |
603 | Ubiquitination | SACLALEKYLDNPNA HHHHHHHHHCCCCCC | 52.54 | 29967540 | |
611 | Ubiquitination | YLDNPNALTERELKV HCCCCCCCCHHHHHH | 6.94 | 29967540 | |
621 | Phosphorylation | RELKVAYTTVLQEWL HHHHHHHHHHHHHHH | 10.74 | 20068231 | |
647 | Phosphorylation | LVRRHLVTFRAMSAR HHHHHHHHHHHHHHH | 17.48 | 23403867 | |
652 | Phosphorylation | LVTFRAMSARLLDYV HHHHHHHHHHHHHHH | 14.84 | 24114839 | |
702 | Phosphorylation | DKQNRAGYSPIMLTA CCCCCCCCCHHHHHH | 15.41 | 22817900 | |
708 | Phosphorylation | GYSPIMLTALATLKT CCCHHHHHHHHHCCC | 11.40 | 29759185 | |
712 | Phosphorylation | IMLTALATLKTQDDI HHHHHHHHCCCCCHH | 29.63 | 29759185 | |
734 | Acetylation | RLGNINAKASQAGQT HHCCCCCCHHHHHHH | 44.04 | 7290057 | |
741 | Phosphorylation | KASQAGQTALMLAVS CHHHHHHHHHHHHHH | 22.35 | 46164097 | |
827 | Phosphorylation | EIASMLYSRMNIKCS HHHHHHHHHCCCEEE | 22.53 | 24719451 | |
843 | Phosphorylation | APMSDDESPTSSSAE CCCCCCCCCCCCCCC | 40.24 | 27251275 | |
845 | Phosphorylation | MSDDESPTSSSAEE- CCCCCCCCCCCCCC- | 50.98 | 27251275 | |
846 | Phosphorylation | SDDESPTSSSAEE-- CCCCCCCCCCCCC-- | 26.19 | 27251275 | |
847 | Phosphorylation | DDESPTSSSAEE--- CCCCCCCCCCCC--- | 35.73 | 27251275 | |
851 (in isoform 2) | Phosphorylation | - | 66.69 | 27251275 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of KANK2_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KANK2_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KANK2_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
NCOA1_HUMAN | NCOA1 | physical | 17476305 | |
NCOA3_HUMAN | NCOA3 | physical | 17476305 | |
NCOA2_HUMAN | NCOA2 | physical | 17476305 | |
KANK2_HUMAN | KANK2 | physical | 25416956 | |
GPSM1_HUMAN | GPSM1 | physical | 25416956 | |
ABI3_HUMAN | ABI3 | physical | 25416956 | |
MOB1A_HUMAN | MOB1A | physical | 25416956 | |
CCD33_HUMAN | CCDC33 | physical | 25416956 | |
CEP70_HUMAN | CEP70 | physical | 25416956 | |
TXLNA_HUMAN | TXLNA | physical | 25416956 | |
IHO1_HUMAN | CCDC36 | physical | 25416956 | |
GOGA2_HUMAN | GOLGA2 | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
616099 | Palmoplantar keratoderma and woolly hair (PPKWH) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Large-scale proteomics analysis of the human kinome."; Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.; Mol. Cell. Proteomics 8:1751-1764(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-375, AND MASSSPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-72; SER-356; SER-375;SER-463 AND THR-472, AND MASS SPECTROMETRY. | |
"ATM and ATR substrate analysis reveals extensive protein networksresponsive to DNA damage."; Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III,Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N.,Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J.; Science 316:1160-1166(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-568, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-375 AND SER-540,AND MASS SPECTROMETRY. |